Ageing and women with bleeding disorders

1 British Menopause Society Council. Modernizing the NHS: observations and recommendations from the British Menopause Society. Menopause Int 2011; 17(2): 41–3. doi: 10.1258/mi.2011.011015. British Menopause Society Council Modernizing the NHS: observations and recommendations from the British Menopause Society Menopause Int 2011 17 2 41 3 10.1258/mi.2011.011015 21693497 Open DOISearch in Google Scholar

2 Daan NMP, Fauser BCJM. Menopause prediction and potential implications. Maturitas 2015; 82(3): 257–265. doi: 10.1016/j.maturitas.2015.07.019. DaanNMP FauserBCJM Menopause prediction and potential implications Maturitas 2015 82 3 257 265 10.1016/j.maturitas.2015.07.019 26278873 Open DOISearch in Google Scholar

3 Duckitt K. Managing perimenopausal menorrhagia. Maturitas 2010; 66(3): 251–256. doi: 10.1016/j.maturitas.2010.03.013. DuckittK Managing perimenopausal menorrhagia Maturitas 2010 66 3 251 256 10.1016/j.maturitas.2010.03.013 20399041 Open DOISearch in Google Scholar

4 Birdwood GF. Understanding Osteoporosis and its Treatment. 1996. Pearl River, NY: The Parthenon Publishing Group, Inc. BirdwoodGF Understanding Osteoporosis and its Treatment 1996 Pearl River, NY The Parthenon Publishing Group, Inc. Search in Google Scholar

5 Burger HG. Androgen production in women. Fertil Steril 2002; 77 Suppl 4: S3–S5. doi: 10.1016/s0015-0282(02)02985-0. BurgerHG Androgen production in women Fertil Steril 2002 77 Suppl 4 S3 S5 10.1016/s0015-0282(02)02985-0 12007895 Open DOISearch in Google Scholar

6 Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep 2004; 119 (3): 263–270. doi: 10.1016/j.phr.2004.04.005. AndersonG HorvathJ The growing burden of chronic disease in America Public Health Rep 2004 119 3 263 270 10.1016/j.phr.2004.04.005 149763815158105 Open DOISearch in Google Scholar

7 Chapin J. Von Willebrand disease in the elderly: clinical perspectives. Clin Interv Aging 2018; 13: 1531–1541. doi: 10.2147/CIA.S136931. ChapinJ Von Willebrand disease in the elderly: clinical perspectives Clin Interv Aging 2018 13 1531 1541 10.2147/CIA.S136931 612446230214173 Open DOISearch in Google Scholar

8 Biguzzi E, Siboni SM, le Cessie S, et al. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease. J Thromb Haemost 2021; 19(1): 96–106. doi: 10.1111/jth.15116. BiguzziE SiboniSM le CessieS Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease J Thromb Haemost 2021 19 1 96 106 10.1111/jth.15116 32998182 Open DOISearch in Google Scholar

9 Rejtö J, Königsbrügge O, Grilz E, et al. Influence of blood group, von Willebrand factor levels and age on factor VIII levels in non-severe haemophilia A. J Thromb Haemost 2020; 18(5): 1081–1086. doi: 10.1111/jth.14770 RejtöJ KönigsbrüggeO GrilzE Influence of blood group, von Willebrand factor levels and age on factor VIII levels in non-severe haemophilia A J Thromb Haemost 2020 18 5 1081 1086 10.1111/jth.14770731858632073230 Open DOISearch in Google Scholar

10 Miesbach W, Alesci S, Krekeler S, Seifried E. Age-dependent increase of FVIII:C in non-severe haemophilia A. Haemophilia 2009; 15(5): 1022–6. doi: 10.1111/j.1365-2516.2009.02051.x. MiesbachW AlesciS KrekelerS SeifriedE Age-dependent increase of FVIII:C in non-severe haemophilia A Haemophilia 2009 15 5 1022 6 10.1111/j.1365-2516.2009.02051.x 19493020 Open DOISearch in Google Scholar

11 Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidies and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15(4): 894–9. doi: 10.1111/j.1365-2516.2009.02030.x. MiesbachW AlesciS KrekelerS SeifriedE Comorbidies and bleeding pattern in elderly haemophilia A patients Haemophilia 2009 15 4 894 9 10.1111/j.1365-2516.2009.02030.x 19473414 Open DOISearch in Google Scholar

12 Seaman CD, Ragni MV. The association of aging with von Willebrand factor levels and bleeding in type 1 von Willebrand disease. Clin Appl Thromb Hemost 2018; 24(3): 434–438. doi: 10.1177/1076029617724232. SeamanCD RagniMV The association of aging with von Willebrand factor levels and bleeding in type 1 von Willebrand disease Clin Appl Thromb Hemost 2018 24 3 434 438 10.1177/1076029617724232 671466428874064 Open DOISearch in Google Scholar

13 Seaman CD, Ragni MV. The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease. Thromb Haemost 2020; 120(08): 1159–1165. doi: 10.1055/s-0040-1713636. SeamanCD RagniMV The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease Thromb Haemost 2020 120 08 1159 1165 10.1055/s-0040-1713636 32629500 Open DOISearch in Google Scholar

14 Bolton-Maggs PHB, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135(5): 603–33. doi: 10.1111/j.1365-2141.2006.06343.x. Bolton-MaggsPHB ChalmersEA CollinsPW A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO Br J Haematol 2006 135 5 603 33 10.1111/j.1365-2141.2006.06343.x 17107346 Open DOISearch in Google Scholar

15 George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75(7): 1383–1395. doi: 10.1182/blood.V75.7.1383.1383. GeorgeJN CaenJP NurdenAT Glanzmann's thrombasthenia: the spectrum of clinical disease Blood 1990 75 7 1383 1395 10.1182/blood.V75.7.1383.1383 Open DOISearch in Google Scholar

16 Casini A, Neerman-Arbez, de Moerloose P. Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management. Blood Rev 2021; 48: 100793. doi: 10.1016/j.blre.2020.100793. CasiniA Neerman-Arbez de MoerlooseP Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management Blood Rev 2021 48 100793 10.1016/j.blre.2020.100793 33419567 Open DOISearch in Google Scholar

17 Siboni SM, Mannucci PM, Gringeri A. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7(5): 780–6. doi: 10.1111/j.1538-7836.2009.03318.x. SiboniSM MannucciPM GringeriA Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy J Thromb Haemost 2009 7 5 780 6 10.1111/j.1538-7836.2009.03318.x 19220727 Open DOISearch in Google Scholar

18 Srámek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362 (9381): 351–354. doi: 10.1016/s0140-6736(03)14021-4. SrámekA KriekM RosendaalFR Decreased mortality of ischaemic heart disease among carriers of haemophilia Lancet 2003 362 9381 351 354 10.1016/s0140-6736(03)14021-4 12907007 Open DOISearch in Google Scholar

19 Schutgens REG, Voskuil M, Mauser-Bunschoten EP. Management of cardiovascular disease in aging persons with haemophilia. Hamostaseologie 2017; 37(3): 196–201. doi: 10.5482/HAMO-16-09-0037. SchutgensREG VoskuilM Mauser-BunschotenEP Management of cardiovascular disease in aging persons with haemophilia Hamostaseologie 2017 37 3 196 201 10.5482/HAMO-16-09-0037 27966004 Open DOISearch in Google Scholar

20 Dilshad H, Yousuf RI, Shoaib MH, Jamil S, Khatoon H. Cardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate. Am J Med Sci 2016; 352(2): 487–492. doi: 10.1016/j.amjms.2016.08.007. DilshadH YousufRI ShoaibMH JamilS KhatoonH Cardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate Am J Med Sci 2016 352 2 487 492 10.1016/j.amjms.2016.08.007 27865296 Open DOISearch in Google Scholar